130 related articles for article (PubMed ID: 21118059)
1. Novel methods to assess bioequivalence.
Karalis V; Symillides M; Macheras P
Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):79-88. PubMed ID: 21118059
[TBL] [Abstract][Full Text] [Related]
2. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
3. Equivalence studies for complex active ingredients and dosage forms.
Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
[TBL] [Abstract][Full Text] [Related]
4. The subject-by-formulation interaction in multivariate bioequivalence.
Cao L; Mathew T
J Biopharm Stat; 2007; 17(3):367-79. PubMed ID: 17479387
[TBL] [Abstract][Full Text] [Related]
5. Sequential design approaches for bioequivalence studies with crossover designs.
Potvin D; DiLiberti CE; Hauck WW; Parr AF; Schuirmann DJ; Smith RA
Pharm Stat; 2008; 7(4):245-62. PubMed ID: 17710740
[TBL] [Abstract][Full Text] [Related]
6. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
Quiroz J; Ting N; Wei GC; Burdick RK
Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
[TBL] [Abstract][Full Text] [Related]
7. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
Chen YI; Huang CS
Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
[TBL] [Abstract][Full Text] [Related]
8. Reference tables for the intrasubject coefficient of variation in bioequivalence studies.
Steinijans VW; Sauter R; Hauschke D; Diletti E; Schall R; Luus HG; Elze M; Blume H; Hoffmann C; Franke G
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):427-30. PubMed ID: 8556220
[TBL] [Abstract][Full Text] [Related]
9. Variability and impact on design of bioequivalence studies.
Van Peer A
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
[TBL] [Abstract][Full Text] [Related]
10. Sample size considerations for establishing clinical bioequivalence of allergen formulations.
Rabin RL; Slater JE; Lachenbruch P; Pastor RW
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):24-33. PubMed ID: 15119019
[TBL] [Abstract][Full Text] [Related]
11. [Harmonization of testing drugs for bioequivalence: problems and possible solutions].
Zherdev VP; Kolyvanov GB; Litvin AA; Sariev AK
Eksp Klin Farmakol; 2003; 66(2):60-4. PubMed ID: 12962051
[TBL] [Abstract][Full Text] [Related]
12. A semi-parametric Bayesian approach to average bioequivalence.
Ghosh P; Rosner GL
Stat Med; 2007 Mar; 26(6):1224-36. PubMed ID: 16832840
[TBL] [Abstract][Full Text] [Related]
13. [Bioequivalence and generic drugs. I. Studies of bioequivalence, considering the theoretical basis, design and use].
Zapater P; Horga JF
Rev Neurol; 1999 Dec 16-31; 29(12):1235-46. PubMed ID: 10652753
[TBL] [Abstract][Full Text] [Related]
14. Striving for standards in bioequivalence assessment: a review.
Schulz HU; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):293-8. PubMed ID: 1743802
[No Abstract] [Full Text] [Related]
15. A method for the evaluation of individual bioequivalence.
Endrenyi L
Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
17. Generic-therapeutic equivalence--enigma or myth?
Shirkey HC
Hawaii Med J; 1970; 29(3):201-2. PubMed ID: 5416016
[No Abstract] [Full Text] [Related]
18. Bioequivalence studies: a new EMA guideline.
Houin G
Arzneimittelforschung; 2010; 60(4):169-70. PubMed ID: 20486464
[No Abstract] [Full Text] [Related]
19. Carryover negligibility and relevance in bioequivalence studies.
Ocaña J; Sanchez O MP; Carrasco JL
Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.
Karalis V; Symillides M; Macheras P
Eur J Pharm Sci; 2009 Aug; 38(1):55-63. PubMed ID: 19524039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
